Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study
- 15 June 2007
- journal article
- research article
- Published by Wiley in Hemodialysis International
- Vol. 11 (3), 340-348
- https://doi.org/10.1111/j.1542-4758.2007.00190.x
Abstract
Abnormalities in mineral metabolism have been linked to mortality in hemodialysis (HD) patients. We postulated that these abnormalities would have a particularly large deleterious impact on deaths due to cardiovascular causes in Japan. This study describes the recent status of abnormal mineral metabolism, significant predictors, and potential consequences in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Phases 1 and 2, in Japan. Major predictor variables were patient demographics, comorbidities, and laboratory markers of mineral metabolism such as albumin‐adjusted serum calcium (calciumAlb), phosphorus, and intact PTH (iPTH). In a cross section of 3973 Japanese HD patients in DOPPS I and II, a large faction had laboratory values outside of the recommended Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline range for serum concentrations of phosphorus (51% of patients above upper target range), calciumAlb (43.7% above), calcium‐phosphorus (Ca × P) product (41.1% above), and iPTH (18.6% above). All‐cause mortality was significantly and independently associated with calciumAlb (relative risk [RR]=1.22 per 1 mg/dL, p=0.0005) and iPTH (RR=1.04 per 100 pg/mL, p=0.04). Cardiovascular mortality was significantly associated with calciumAlb (RR=1.28, p=0.02), phosphorus (RR=1.13 per 1 mg/dL, p=0.008), Ca × P product (RR=1.07 per 2 mg2/dL2, p=0.002), and PTH (RR=1.08, p=0.0001). This study expands our understanding of the relationship between altered mineral metabolism and mortality outcomes, showing slightly stronger associations with cardiovascular causes than observed for all‐cause mortality. These findings have important therapeutic implications for Japanese HD patients.Keywords
This publication has 16 references indexed in Scilit:
- Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns StudyKidney International, 2005
- Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitroKidney International, 2004
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Calcium Phosphate Metabolism and Cardiovascular Disease in Patients with Chronic Kidney DiseaseSeminars in Dialysis, 2003
- Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cellsKidney International, 2002
- Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease?Journal of the American College of Cardiology, 2002
- Association of Elevated Serum PO4, Ca × PO4 Product, and Parathyroid Hormone with Cardiac Mortality Risk in Chronic Hemodialysis PatientsJournal of the American Society of Nephrology, 2001
- Phosphate Regulation of Vascular Smooth Muscle Cell CalcificationCirculation Research, 2000
- Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing DialysisThe New England Journal of Medicine, 2000
- Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national studyAmerican Journal of Kidney Diseases, 1998